SLC5A2 and type 2 diabetes mellitus: ("type 2 diabetes mellitus" OR T2DM) AND ("SGLT2 inhibitor" OR empagliflozin OR dapagliflozin OR canagliflozin) AND ("cognitive decline" OR dementia OR "cognitive impairment" OR "Alzheimer disease")